ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1949

The p.R321C Mutation in P62 Associated with Paget’s Disease of Bone Leads to a Change of Localization of the Protein in Human Osteoclasts

Nerea Gestoso-Uzal 1, Ricardo Usategui-Martín 1, Rogelio González-Sarmiento 1 and Javier Del Pino-Montes1, 1Salamanca Institute of Biomedical Research (IBSAL), University Hospital of Salamanca- University of Salamanca, Salamanca-CSIC, Spain, Salamanca, Castilla y Leon, Spain

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: autophagy proteins, bone metabolism, osteoclasts and disease susceptibility, Paget's disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Paget´s disease of bone (PDB) is a chronic bone metabolic disorder. Currently, PDB is a focal disorder characterized by an increase in bone turnover in a disorganized way. Its cause is unknown, but it is clear that it is a multifactorial disease in which genetic and environmental factors are involved. The most important known genetic factor predisposing to PDB is mutation in Sequestosome1 (SQSTM1) gene. This gene encodes p62, a multifunctional protein involved in autophagy that binds ubiquitin and regulates activation of the nuclear factor kappa-B (NF-kB) signaling pathway, regulating autophagy. We detected for the first time the c.961C >T SQSTM1 gene mutation localized in exon 6 of SQSTM1 gene in three PDB patients. It causes the p.R321C mutation, localized in the LIR domain of p62 protein. The aim of this study is to characterize the effect of the p.R321C mutation in human osteoclasts.

Methods: First of all, the SQSTM1 cDNA was cloned into the EcoRI site of the pCEFL-Flag vector to generate the pCEFL-Flag-cSQSTM1-321wt construct. The p.R321C mutation was introduced into this construct by mutagenesis using primers designed to introduce C >T base change at position +961 to generate pCEFL-Flag-cSQSTM1-321C construct. After that, PBMCs were isolated from venous blood samples for generating human osteoclasts in vitro, using Ficoll.  Mononuclear cells were seeded in 6-well culture plates with glass cover slips and cultured with α-MEM medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin at 37ºC in a humidified 5% CO2 atmosphere. Cells were differentiated with fresh α-MEM containing M-CSF and RANKL every 3 days for 3 weeks. After that, the cells were transiently transfected with total plasmid DNA (pCEFL-Flag-cSQSTM1-321wt and pCEFL-Flag-cSQSTM1-321C). 72 hours after transfection cells were fixed and we performed a Confocal Co-Immunofluorescence Assay, using as primary antibodies anti-Flag M2 and anti-p62. Also, cells were stained with DAPI (4’, 6-diamidino-2-phenylindole), to select the ones with at least 3 nuclei. Fluorescence images were captured with a confocal microscope.

Results: Our results showed that, while endogenous p62 remains scattered though the cytoplasm, p.R321C p62 is concentrated in the periphery of human osteoclasts. Transfection with WT p62 showed the same localization that endogenous WT p62. This change of localization caused by the mutation detected in PDB patients could result in an alteration in autophagy that can have an important role in the development of PDB, since autophagy is a catabolic process that occurs in the cytoplasm. In fact, previous studies have associated other mutations in autophagy genes with the physiopathology of PDB. To confirm the effect of this mutation in autophagy functional studies are ongoing.

Conclusion: The mutation p.R321C in the LIR domain of p62 protein leads to a change of localization of the protein in human osteoclasts, reinforcing the hypothesis that autophagy is involved in PDB.


Disclosure: N. Gestoso-Uzal, None; R. Usategui-Martín, None; R. González-Sarmiento, None; J. Del Pino-Montes, None.

To cite this abstract in AMA style:

Gestoso-Uzal N, Usategui-Martín R, González-Sarmiento R, Del Pino-Montes J. The p.R321C Mutation in P62 Associated with Paget’s Disease of Bone Leads to a Change of Localization of the Protein in Human Osteoclasts [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-p-r321c-mutation-in-p62-associated-with-pagets-disease-of-bone-leads-to-a-change-of-localization-of-the-protein-in-human-osteoclasts/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-p-r321c-mutation-in-p62-associated-with-pagets-disease-of-bone-leads-to-a-change-of-localization-of-the-protein-in-human-osteoclasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology